Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for immunobullous diseases, diabetes mellitus, and prostate cancer.
ARUP offers several antibody panels to test for immunobullous diseases, which are difficult to diagnose. The Immunobullous Disease Testing Comparison tool allows users to quickly compare test options.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on newborn drug screening and noninvasive prenatal testing.
Noninvasive prenatal testing (NIPT) provides critical information to expectant parents. ARUP has updated its test offerings to include the most sensitive and specific alternatives available.
ARUP Consult has released new and updated resources on testing for viral hepatitis and nephrolithiasis (i.e., kidney stone disease).
ARUP Consult®, a free source of expert guidance in laboratory testing, has released updated resources on testing for group A Streptococcus, Toxocara, and Echinococcus infections.
Cases of Lyme disease, Rocky Mountain spotted fever, and other tickborne illnesses are rising across the U.S. ARUP Consult’s testing resources can aid clinicians in diagnosing tickborne diseases.
ARUP Consult has released updated resources on Endocrine Testing in Transgender Adults and diagnosis of Male Hypogonadism. Also new are two comparison tools for ARUP’s testosterone and estrogen tests.
ARUP Consult® has released new and updated resources on Prenatal Testing for Chromosomal Abnormalities and Neural Tube Defects, Soft Tissue Sarcomas, and COVID.
ARUP Consult®, a free source of expert guidance in laboratory testing, has released updated resources on testing for celiac disease and trace element deficiency and toxicity.
ARUP Consult® has released updated resources on Hereditary Thrombophilia, Group B Streptococcal Disease, and Paraneoplastic Neurologic Syndromes (PNSs).